Global Immuno-oncology Diagnosis Market Growth Status and Outlook 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immuno-oncology Diagnosis Market Size 2016-2026
2.1.2 Immuno-oncology Diagnosis Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Immuno-oncology Diagnosis Segment by Technology
2.2.1 PCR
2.2.2 PCR
2.2.3 Immunoassay
2.3 Immuno-oncology Diagnosis Market Size by Technology
2.3.1 Global Immuno-oncology Diagnosis Market Size CAGR by Technology
2.3.2 Global Immuno-oncology Diagnosis Market Size Market Share by Technology (2016-2021)
2.4 Immuno-oncology Diagnosis Segment by Application
2.4.1 Research
2.4.2 Diagnostics
2.5 Immuno-oncology Diagnosis Market Size by Application
2.5.1 Global Immuno-oncology Diagnosis Market Size CAGR by Application
2.5.2 Global Immuno-oncology Diagnosis Market Size Market Share by Application (2016-2021)

3 Immuno-oncology Diagnosis Market Size by Players
3.1 Immuno-oncology Diagnosis Market Size Market Share by Players
3.1.1 Global Immuno-oncology Diagnosis Revenue by Players (2019-2021E)
3.1.2 Global Immuno-oncology Diagnosis Revenue Market Share by Players (2019-2021E)
3.2 Global Immuno-oncology Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Immuno-oncology Diagnosis by Regions
4.1 Immuno-oncology Diagnosis Market Size by Regions (2016-2021)
4.2 Americas Immuno-oncology Diagnosis Market Size Growth (2016-2021)
4.3 APAC Immuno-oncology Diagnosis Market Size Growth (2016-2021)
4.4 Europe Immuno-oncology Diagnosis Market Size Growth (2016-2021)
4.5 Middle East & Africa Immuno-oncology Diagnosis Market Size Growth (2016-2021)

5 Americas
5.1 Americas Immuno-oncology Diagnosis Market Size by Country (2016-2021)
5.2 Americas Immuno-oncology Diagnosis Market Size by Technology (2016-2021)
5.3 Americas Immuno-oncology Diagnosis Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Immuno-oncology Diagnosis Market Size by Region (2016-2021)
6.2 APAC Immuno-oncology Diagnosis Market Size by Technology (2016-2021)
6.3 APAC Immuno-oncology Diagnosis Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Immuno-oncology Diagnosis by Country (2016-2021)
7.2 Europe Immuno-oncology Diagnosis Market Size by Technology (2016-2021)
7.3 Europe Immuno-oncology Diagnosis Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Immuno-oncology Diagnosis by Region (2016-2021)
8.2 Middle East & Africa Immuno-oncology Diagnosis Market Size by Technology (2016-2021)
8.3 Middle East & Africa Immuno-oncology Diagnosis Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Immuno-oncology Diagnosis Market Forecast
10.1 Global Immuno-oncology Diagnosis Forecast by Regions (2021-2026)
10.1.1 Global Immuno-oncology Diagnosis Forecast by Regions (2021-2026)
10.1.2 Americas Immuno-oncology Diagnosis Forecast
10.1.3 APAC Immuno-oncology Diagnosis Forecast
10.1.4 Europe Immuno-oncology Diagnosis Forecast
10.1.5 Middle East & Africa Immuno-oncology Diagnosis Forecast
10.2 Americas Immuno-oncology Diagnosis Forecast by Countries (2021-2026)
10.2.1 United States Immuno-oncology Diagnosis Market Forecast
10.2.2 Canada Immuno-oncology Diagnosis Market Forecast
10.2.3 Mexico Immuno-oncology Diagnosis Market Forecast
10.2.4 Brazil Immuno-oncology Diagnosis Market Forecast
10.3 APAC Immuno-oncology Diagnosis Forecast by Region (2021-2026)
10.3.1 China Immuno-oncology Diagnosis Market Forecast
10.3.2 Japan Immuno-oncology Diagnosis Market Forecast
10.3.3 Korea Immuno-oncology Diagnosis Market Forecast
10.3.4 Southeast Asia Immuno-oncology Diagnosis Market Forecast
10.3.5 India Immuno-oncology Diagnosis Market Forecast
10.3.6 Australia Immuno-oncology Diagnosis Market Forecast
10.4 Europe Immuno-oncology Diagnosis Forecast by Country (2021-2026)
10.4.1 Germany Immuno-oncology Diagnosis Market Forecast
10.4.2 France Immuno-oncology Diagnosis Market Forecast
10.4.3 UK Immuno-oncology Diagnosis Market Forecast
10.4.4 Italy Immuno-oncology Diagnosis Market Forecast
10.4.5 Russia Immuno-oncology Diagnosis Market Forecast
10.5 Middle East & Africa Immuno-oncology Diagnosis Forecast by Region (2021-2026)
10.5.1 Egypt Immuno-oncology Diagnosis Market Forecast
10.5.2 South Africa Immuno-oncology Diagnosis Market Forecast
10.5.3 Israel Immuno-oncology Diagnosis Market Forecast
10.5.4 Turkey Immuno-oncology Diagnosis Market Forecast
10.5.5 GCC Countries Immuno-oncology Diagnosis Market Forecast
10.6 Global Immuno-oncology Diagnosis Forecast by Technology (2021-2026)
10.7 Global Immuno-oncology Diagnosis Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 10x Genomics
11.1.1 10x Genomics Company Information
11.1.2 10x Genomics Immuno-oncology Diagnosis Product Offered
11.1.3 10x Genomics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 10x Genomics Main Business Overview
11.1.5 10x Genomics Latest Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Immuno-oncology Diagnosis Product Offered
11.2.3 Abbott Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Abbott Laboratories Main Business Overview
11.2.5 Abbott Laboratories Latest Developments
11.3 Abcam
11.3.1 Abcam Company Information
11.3.2 Abcam Immuno-oncology Diagnosis Product Offered
11.3.3 Abcam Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Abcam Main Business Overview
11.3.5 Abcam Latest Developments
11.4 Adaptive Biotechnologies
11.4.1 Adaptive Biotechnologies Company Information
11.4.2 Adaptive Biotechnologies Immuno-oncology Diagnosis Product Offered
11.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Adaptive Biotechnologies Main Business Overview
11.4.5 Adaptive Biotechnologies Latest Developments
11.5 Aethlon Medical
11.5.1 Aethlon Medical Company Information
11.5.2 Aethlon Medical Immuno-oncology Diagnosis Product Offered
11.5.3 Aethlon Medical Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Aethlon Medical Main Business Overview
11.5.5 Aethlon Medical Latest Developments
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Information
11.6.2 Agena Bioscience Immuno-oncology Diagnosis Product Offered
11.6.3 Agena Bioscience Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Agena Bioscience Main Business Overview
11.6.5 Agena Bioscience Latest Developments
11.7 Angle plc
11.7.1 Angle plc Company Information
11.7.2 Angle plc Immuno-oncology Diagnosis Product Offered
11.7.3 Angle plc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Angle plc Main Business Overview
11.7.5 Angle plc Latest Developments
11.8 Apocell
11.8.1 Apocell Company Information
11.8.2 Apocell Immuno-oncology Diagnosis Product Offered
11.8.3 Apocell Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Apocell Main Business Overview
11.8.5 Apocell Latest Developments
11.9 ARUP Laboratories
11.9.1 ARUP Laboratories Company Information
11.9.2 ARUP Laboratories Immuno-oncology Diagnosis Product Offered
11.9.3 ARUP Laboratories Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 ARUP Laboratories Main Business Overview
11.9.5 ARUP Laboratories Latest Developments
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Information
11.10.2 Beckman Coulter Immuno-oncology Diagnosis Product Offered
11.10.3 Beckman Coulter Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Beckman Coulter Main Business Overview
11.10.5 Beckman Coulter Latest Developments
11. Becton Dickinson
11.11.1 Becton Dickinson Company Information
11.11.2 Becton Dickinson Immuno-oncology Diagnosis Product Offered
11.11.3 Becton Dickinson Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Becton Dickinson Main Business Overview
11.11.5 Becton Dickinson Latest Developments
11.12 Bioarray Genetics
11.12.1 Bioarray Genetics Company Information
11.12.2 Bioarray Genetics Immuno-oncology Diagnosis Product Offered
11.12.3 Bioarray Genetics Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Bioarray Genetics Main Business Overview
11.12.5 Bioarray Genetics Latest Developments
11.13 BioCartis
11.13.1 BioCartis Company Information
11.13.2 BioCartis Immuno-oncology Diagnosis Product Offered
11.13.3 BioCartis Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 BioCartis Main Business Overview
11.13.5 BioCartis Latest Developments
11.14 Biocept
11.14.1 Biocept Company Information
11.14.2 Biocept Immuno-oncology Diagnosis Product Offered
11.14.3 Biocept Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Biocept Main Business Overview
11.14.5 Biocept Latest Developments
11.15 Biodesix Inc
11.15.1 Biodesix Inc Company Information
11.15.2 Biodesix Inc Immuno-oncology Diagnosis Product Offered
11.15.3 Biodesix Inc Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Biodesix Inc Main Business Overview
11.15.5 Biodesix Inc Latest Developments
11.16 BioFluidica
11.16.1 BioFluidica Company Information
11.16.2 BioFluidica Immuno-oncology Diagnosis Product Offered
11.16.3 BioFluidica Immuno-oncology Diagnosis Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 BioFluidica Main Business Overview
11.16.5 BioFluidica Latest Developments
11.17 BioGenex 40 bioM